European Urology Focus

Article	Citations
Longitudinal Evaluation of Perineogenital Pain and Postoperative Complications After One-stage Buccal Mucosal Graft Urethroplasty: A Secondary Analysis of a Randomized Controlled Trial	132
Re: Panagiotis Kallidonis, Constantinos Adamou, Dimitrios Kotsiris, et al. Combination Therapy with Alpha-blocker and Phosphodiesterase-5 Inhibitor for Improving Lower Urinary Tract Symptoms and Erect	107
Re: Farha Pirani, Salima S. Makhani, Frances Y. Kim, et al. Prospective Randomized Trial Comparing the Safety and Clarity of Water Versus Saline Irrigant in Ureteroscopy. Eur Urol Focus. In press. htt	64
Reply to Eugenio Ventimiglia, Steeve Doizi, Andrea Salonia, and Olivier Traxer's Letter to the Editor re: Farha Pirani, Salima S. Makhani, Frances Y. Kim, et al. Prospective Randomized Trial Comparing	63
Medium-term Oncological Efficacy and Patient-reported Outcomes After Focal High-intensity Focused Ultrasound: The FOXPRO Trial	59
New TENSI+ Device for Transcutaneous Posterior Tibial Nerve Stimulation: A Prospective, Multicentre, Post-market Clinical Study	59
Treatment Success After Urethroplasty: The Ongoing Quest for a Pragmatic and Universal Definition	55
Re: Lazaros Tselves, Robert Geraghty, Riccardo Lombardo, et al. Duration of Follow-up and Timing of Discharge from Imaging Follow-up, in Adult Patients with Urolithiasis After Surgical or Medical Inte	52
Incidence and Outcomes of Secondary Bladder Cancer Following Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-analysis	51
Radical Transurethral Resection of Bladder Tumor in Organ-confined Muscle-invasive Bladder Cancer: Yes!	51
Prostate-specific Membrane Antigen–radioguided Surgery in an EMBARK-like Cohort of Patients with Oligorecurrent Hormone-sensitive Prostate Cancer: Delay in Systemic Treatment	47
Contents	47
Risk Prediction Models for Kidney Cancer: A Systematic Review	46
Integrating Prehabilitation into the Cancer Survivorship Framework	44
Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade N	43
Reply to Cosimo De Nunzio, Giacomo Novara, Rocco Damiano, Riccardo Bartoletti, Andrea Tubaro, and Vincenzo Ficarra’s Letter to the Editor re: Giorgio Ivan Russo, Carmen Scandura, Marina Di Mauro, et a	42
Contents	41
Prostate-specific Membrane Antigen Radioguidance for Salvage Lymph Node Dissection in Recurrent Prostate Cancer	41
The Emerging Role of Extracranial Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma: A Systematic Review	40
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy	40
Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non–Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review	40
Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis	38
Fertility Preservation Is Recommended in Adolescents with Klinefelter Syndrome: Con	37
The “Natural History” of Evidence on Radical Prostatectomy: What Have 20 Years of Robots Given Us?	37
Re: Gregory W. Hosier, Thomas McGregor, Darren Beiko, et al. Persistent Opioid Use Among Patients with Urolithiasis: A Population based Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2	37

Data Availability Statements and Data Sharing in Urology: A False Promise?	36
Europa Uomo Patient Reported Outcome Study (EUPROMS): Descriptive Statistics of a Prostate Cancer Survey from Patients for Patients	36
Contents	36
Evidence-based Urology: Subgroup Analysis in Randomized Controlled Trials	35
Biomarkers of Response to Anti-NECTIN4 Antibody-Drug Conjugate Enfortumab Vedotin in Urothelial Cancer	35
The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm	34
Redefining the Gender Gap in Urology Authorship: An 18-Year Publication Analysis	33
When and How To Perform Active Surveillance for Low-risk Non–muscle-invasive Bladder Cancer	33
Editorial Board	32
Systematic Analysis of the Global, Regional and National Burden of Kidney Cancer from 1990 to 2017: Results from the Global Burden of Disease Study 2017	32
Re: Bara Barakat, Hazem Othman, Ulrich Gauger, Ingmar Wolff, Boris Hadaschik, Christian Rehme. Retzius Sparing Radical Prostatectomy Versus Robot-assisted Radical Prostatectomy: Which Technique Is Mor	32
Prostate-specific Antigen Screening Using the Traditional Cut Point of 3 ng/ml: Con	30
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of P	30
Contents	30
Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate	30
Reply to Carmen Gravina, Riccardo Lombardo, and Cosimo De Nunzio’s Letter to the Editor re: Yash S. Khandwala, Simon John Christoph Soerensen, Shravan Morisetty, et al. The Association of Tissue Chang	29
Re: Roselyne Choinière, Philippe D. Violette, Mélanie Morin, et al. Evaluation of Benefits and Harms of Surgical Treatments for Post–radical Prostatectomy Urinary Incontinence: A Systematic Review and	29
Re: Yash S. Khandwala, Simon John Christoph Soerensen, Shravan Morisetty, et al. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prost	29
Belzutifan Efficacy and Tolerability in Patients with Sporadic Metastatic Clear Cell Renal Cell Carcinoma	29
Contents	28
Re: Moritz von Büren, Severin Rodler, Isabell Wiesenhütter, et al. Digital Real-world Data Suggest Patient Preference for Tadalafil over Sildenafil in Patients with Erectile Dysfunction. Eur Urol Focu	28
Contents	27
From Avoiding Overtreatment and Undertreatment to Delivering the Right Therapy at the Right Time for the Right Tumor in the Right Patient: The Age of the Thoughtful Urologic Oncologic Surgeon Has Begu	27
Optimal Strategies for Managing Prostate-specific Antigen Recurrence After Primary Radiotherapy in Prostate Cancer: The Finnish Perspective	27
Prospective Randomized Trial Comparing the Safety and Clarity of Water Versus Saline Irrigant in Ureteroscopy	26
Reply to Hsiao-Chun Chang and Shiu-Dong Chung’s Letter to the Editor re: Britta Grüne, F abian Siegel, Frank Waldbillig, et al. Long-term Reinterventions after Thulium Laser Enucleation of the Prostat	26
Bladder Chemoprophylaxis Following Ureterorenoscopy in Patients with Upper Tract Urothelial Carcinoma	26
Erectile and Ejaculatory Function Following Anterior Urethroplasty: A Systematic Review and Meta-analysis	26
Reply to: Antonio Andrea Grosso, Agostino Tuccio, Matteo Salvi, Daniele Paganelli, Andrea Minervini, and Fabrizio Di Maida’s Letter to the Editor re: Paolo Capogrosso, Eugenio Ventimiglia, Giuseppe Fa	26
Survival of Patients with Chronic Kidney Disease Treated with Radical Cystectomy and Risk Factors of Glomerular Filtration Rate Loss Following Radical Cystectomy: Two Systematic Reviews and Meta-analy	26
How Can We Understand Patients’ Values, Preferences, and Expectations in Urology?	26
Intermittent Androgen Deprivation for Biochemically Recurrent Prostate Cancer: First Do No Harm	25
Reply to Francesco Montorsi, Giorgio Gandaglia, Federico Dehò, Elio Mazzone, Armando Stabile, and Alberto Briganti’s Letter to the Editor re: Dries Develtere, Giuseppe Rosiello, Pietro Piazza, et al.	25
Editorial Board	25
Re: Gopal Sharma, Milap Shah, Puneet Ahluwalia, et al. Development and Validation of a Nomogram Predicting Intraoperative Adverse Events During Robot-assisted Partial Nephrectomy. Eur Urol Focus 2023;	25
Reply to Francesco Montorsi, Armando Stabile, Giorgio Gandaglia, and Alberto Briganti’s Letter to the Editor re: K.R. Seetharam Bhat, Marcio Covas Moschovas, Marco Sandri, et al. Outcomes of Salvage R	25
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients	24
Comparison of Patient-reported Health-related Quality of Life Between Open Radical Cystectomy and Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Interim Analysis of a Randomi	23
Radiomics for Renal Cell Carcinoma: Predicting Outcomes from Immunotherapy and Targeted Therapies—A Narrative Review	23
Re: Carlo A. Bravi, Marco Paciotti, Eleonora Balestrazzi, et al. Outcomes of Robot-assisted Radical Prostatectomy with the Hugo RAS Surgical System: Initial Experience at a High-volume Robotic Center.	22
Vesicourethral Anastomotic Stenosis After Open or Robot-assisted Laparoscopic Retropubic Prostatectomy—Results from the Laparoscopic Prostatectomy Robot Open Trial	22
Management of Urosymphyseal Fistula and Pelvic Osteomyelitis: A Comprehensive Institutional Experience and Improvements in Pain Control	22
Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2 Project)	22
Prehabilitation in Urology: Trial Update	22
Spermatogonial Stem Cells and In Vitro Spermatogenesis: How Far Are We from a Human Testis on a Chip?	22
Hot Topics in the Clinical Practice Guidelines for Treatment of Male Lower Urinary Tract Symptoms due to Benign Prostatic Obstruction	21
Physician Perception of Grade Group 1 Prostate Cancer	21
Oncological Long-term Outcome After Whole-gland High-intensity Focused Ultrasound for Prostate Cancer—21-yr Follow-up	21
Developing Free Three-dimensional Software for Surgical Planning for Kidney Stones: Volume is Better than Diameter	21
The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy	20

Total Pelvic Exenteration for Locally Advanced and Recurrent Rectal Cancer: Urological Outcomes and Adverse Events	20
Genomic Sequencing Should Not be Part of the Standard of Care for Most Urologic Cancers	20
Re: Rui Farinha, Giuseppe Rosiello, Artur De Oliveira Paludo, et al. Selective Suturing or Sutureless Technique in Robot-assisted Partial Nephrectomy: Results from a Propensity-score Matched Analysis.	20
Variation and Disparity in the Use of Prostate Cancer Risk Stratification Tools in the United States	20
Robot-assisted Versus Conventional Laparoscopic Radical Prostatectomy: A Systematic Review and Meta-analysis of Randomised Controlled Trials	20
Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and Surgery	19
Benefits and Harms of Conservative, Pharmacological, and Surgical Management Options for Women with Bladder Outlet Obstruction: A Systematic Review from the European Association of Urology Non-neuroge	19
Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation—A Multicenter Validation Study	19
Superselective Ischemia in Robotic Partial Nephrectomy Does Not Provide Better Long-term Renal Function than Renal Artery Clamping in a Randomized Controlled Trial (EMERALD): Should We Take the Risk?	19
Survival of Patients with Metastatic Prostate Cancer After Disease Progression on an Androgen Receptor Axis–Targeted Therapy Given in the Metastatic Castration-Sensitive Versus Metastatic Castration-R	19
Efficacy and Safety of Eliapixant in Overactive Bladder: The 12-Week, Randomised, Placebo-controlled Phase 2a OVADER Study	19
Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality–free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients	19
The Importance of Terminology for Quantifying Nocturia in Practice	19
Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical Prostatectomy	18
Expression of Programmed Cell Death Ligand 1 as a Predictive Biomarker in Metastatic Urothelial Carcinoma Patients Treated with First-line Immune Checkpoint Inhibitors Versus Chemotherapy: A Systemati	18
Risks and Benefits of Live Surgical Broadcast: A Systematic Review	18
Pilot Study: Next-generation Sequencing of the Semen Microbiome in Vasectomized Versus Nonvasectomized Men	18
Nocebo Response in the Pharmacological Management of Overactive Bladder: A Systematic Review and Meta-analysis	18
Evaluating the Certainty of Evidence in Evidence-based Medicine	18
Predictors of Poor Response and Adverse Events Following Botulinum Toxin A for Refractory Idiopathic Overactive Bladder: A Systematic Review	18
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: An Updated Network Meta-analysis Including ARANOTE Data	18
The Power of Hashtags in Social Media: Lessons Learnt from the Urology Tag Ontology Project	18
Negative Predictive Value of Biparametric Prostate Magnetic Resonance Imaging in Excluding Significant Prostate Cancer: A Pooled Data Analysis Based on Clinical Data from Four Prospective, Registered	17
Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherap	17
Re: Antonio Andrea Grosso, Agostino Tuccio, Matteo Salvi, Daniele Paganelli, Andrea Minervini, and Fabrizio Di Maida’s Letter to the Editor re: Paolo Capogrosso, Eugenio Ventimiglia, Giuseppe Fallara,	17
Detailing Sexual Outcomes After Focal Therapy for Localised Prostate Cancer: A Systematic Review and Meta-analysis	17
Late Toxicities of Prostate Radiotherapy: Can We Further SMARTen Up the Therapeutic Index?	17
Chromosomal Instability in Cell-free DNA as a Prognostic Biomarker of Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation Therapy	17
Magnetic Resonance Imaging Follow-up of Targeted Biopsy–negative Prostate Lesions	17
A Double-blind, Randomised Four-way Crossover Study to Compare the Effects of Fesoterodine 4 and 8 mg Once Daily and Qxybutynin 5 mg Twice Daily After Steady-state Dosing Versus Placebo on Cognitive F	17
Evidence-based Urology: Trustworthy Guidelines	16
Fixed-effect Versus Random-effects Models for Meta-analyses: Random-effects Models	16
A Contemporary Case Series of Complex Surgical Repair of Surgical/Endoscopic Injuries to the Abdominal Ureter	16
Simplified PADUA Renal (SPARE) Nephrometry Scoring System: External Validation, Interobserver Variability, and Comparison with RENAL and PADUA in a Single-center Robotic Partial Nephrectomy Series	16
Routine Preoperative Bone Scintigraphy Has Limited Impact on the Management of Patients with Invasive Bladder Cancer	16
Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Associatio	16
Designing and Implementing a Population-based Organised Prostate Cancer Testing Programme	16
Initial Experience with Apixaban for Extended Venous Thromboembolism Prophylaxis After Radical Cystectomy	16
European Association of Urology Section of Urolithiasis and International Alliance of Urolithiasis Joint Consensus on Retrograde Intrarenal Surgery for the Management of Renal Stones	15
Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial Nephrectomy	15
The Association Between Insomnia, Insomnia Medications, and Erectile Dysfunction	15
ARTS: A Large, International Trial of Thromboprophylaxis in Intra-abdominal, Gynecologic, and Urologic Surgery	15
External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort	15
A Multi-institution Study on the Association of Virtual Reality Skills with Continence Recovery after Robot-assisted Radical Prostatectomy	15
Associations of PTEN and ERG with Magnetic Resonance Imaging Visibility and Assessment of Non–organ-confined Pathology and Biochemical Recurrence After Radical Prostatectomy	15
Prostate Surgery for Men with Lower Urinary Tract Symptoms: Do We Need Urodynamics to Find the Right Candidates? Exploratory Findings from the UPSTREAM Trial	15
Holmium Laser En-bloc Resection Versus Conventional Transurethral Resection of Bladder Tumors for Treatment of Non–muscle-invasive Bladder Cancer: A Randomized Clinical Trial	14
Clinical Consultation Guide: Nerve-sparing Techniques for Retroperitoneal Lymph Node Dissection in Testicular Cancer	14
Does MOSES Technology Enhance the Efficiency and Outcomes of Standard Holmium Laser Enucleation of the Prostate? Results of a Systematic Review and Meta-analysis of Comparative Studies	14
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery Guidelines	14
The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer	14
Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma	14
Evidence-based urology: understanding GRADE methodology	14
Retroperitoneal Lymph Node Dissection in Patients with Stage II Seminomatous Germ Cell Tumour	14
Oncologic and Safety Outcomes for Endoscopic Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An Updated Systematic Review and Meta-analysis	14
Quality Indicators in the Clinical Specialty of Urology: A Systematic Review	14
Surgical Metastasectomy for Visceral and Bone Prostate Cancer Metastases: A Mini-Review	14
Emerging Technologies for the Surgical Management of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Obstruction. A Systematic Review	14
Re: Tatsushi Kawada, Ekaterina Laukhtina, Fahad Quhal, et al. Oncologic and Safety Outcomes for Endoscopic Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An Updated Sy	14
Impact of the Standardization of Penile Cancer Care on the Quality of Care, Outcomes, and Academic-driven Centralization in a Single eUROGEN Referral Center	14
Long-term Follow-up of Intravesical Onabotulinum Toxin-A Injections in Male Patients with Idiopathic Overactive Bladder: Comparing Surgery-naïve Patients and Patients After Prostate Surgery	14
Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Obstruction: 5-year Outcomes of a Randomised, Open-label, Noninferiority Trial	13
Update on APPEAL, an International Randomized Controlled Trial Evaluating Ciprofloxacin Versus Placebo in Patients Undergoing Shockwave Lithotripsy for Urolithiasis	13
Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors	13
Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II Trial	13
Orchidopexy for Testicular Torsion: A Systematic Review of Surgical Technique	13
Prostate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications	13
Cost-effectiveness Analysis of 99mTc-sestamibi SPECT/CT to Guide Management of Small Renal Masses	13
Diagnostic Utility of Artificial Intelligence–assisted Transperineal Biopsy Planning in Prostate Cancer Suspected Men: A Prospective Cohort Study	13
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours: Initial Experience in a Multicentre Cohort	13
Oncologic Outcome of the Extent of Pelvic Lymph Node Dissection During Radical Prostatectomy: A Systematic Review, Meta-analysis, and Network Analysis	13
Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis	13
Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve	13
The Financial Burden of Guideline-recommended Cancer Medications for Metastatic Urothelial Carcinoma	13
Urodynamic Risk Factors for Urinary Infection	13
Impact of Synchronous versus Metachronous Metastasis on Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with First-line Immune Checkpoint Inhibitor–based Combinations	13
International Expert Consensus on Metric-based Characterization of Robot-assisted Partial Nephrectomy	13
Morcellation After Endoscopic Enucleation of the Prostate: Efficiency and Safety of Currently Available Devices	13
The Intraoperative Complications Assessment and Reporting with Universal Standards (ICARUS) Global Surgical Collaboration Project: Development of Criteria for Reporting Adverse Events During Surgical	13
Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors	13

Safety and Efficacy of Vaginal Implants in Pelvic Organ Prolapse Surgery: A Meta-analysis of 161 536 Patients	12
Microbiome-based Therapeutics: Cutting-edge Innovation	12
Potential Applications of New Headsets for Virtual and Augmented Reality in Urology	12
Data Mining in Urology: Understanding Real-world Treatment Pathways for Lower Urinary Tract Systems via Exploration of Big Data	12
Serum Levels of MicroRNA-371a-3p for Predicting the Histology of Postchemotherapy Residual Masses of Germ Cell Tumours	12
Salvage Radical Prostatectomy for Recurrent Prostate Cancer After Primary Nonsurgical Treatment: An Updated Systematic Review	12
Is Engineered Tissue the Future of Bladder Reconstruction: Con	12
Re: Jakob Klemm, Michael Rink, Markus von Deimling, et al. Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association	12
Corrigendum to “A systematic review and meta-analysis on the impact of infertility on men’s general health” [Eur. Urol. Focus (2023) 10(1):98–106.]	12
Reply to: Rong Dai and Changkai Deng’s Letter to the Editor re: Anirban Dey, Georgios Georgiadis, Justin Umezurike, et al. Mirabegron Versus Placebo and Other Therapeutic Modalities in the Treatment o	12
Machine Learning and External Validation of the IDENTIFY Risk Calculator for Patients with Haematuria Referred to Secondary Care for Suspected Urinary Tract Cancer	12
Ethical implications of AI in robotic surgical training: A Delphi consensus statement	12
Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography–guided Salvage Radiotherapy Following Prostatectomy	12
New Drugs for Targeted Radionuclide Therapy in Metastatic Prostate Cancer	12
Association of 5α-Reductase Inhibitors with Depression and Suicide: A Mini Systematic Review and Meta-analysis	12
Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis of Individual Patient Data	12
Interleukins in Urine and Blood as Markers of Infection and as Risk Factors for Systemic Conditions	12
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer	12
Receptor Activator of NF Kappa B (RANK) Expression Indicates Favorable Prognosis in Patients with Muscle-invasive Bladder Cancer	11
Editorial Board	11
Contents	11
Contents	11
Re: Xuesong Li, Weifeng Xu, Shubo Fan, et al. Robot-assisted Partial Nephrectomy with the Newly Developed KangDuo Surgical Robot Versus the da Vinci Si Surgical System: A Double-center Prospective Ran	11
The Differential Risk of Mortality Among Users of Overactive Bladder Anticholinergic Medications and β3 Agonists	11
Reply to Bernardo Rocco and Maria Chiara Sighinolfi’s Letter to the Editor re: Romain Diamand, Jean-Baptiste Roche, Elena Lievore, et al. External Validation of Models for Prediction of Side-specific	11
How Best to Implement Climate-smart Actions in Clinical Urologic Care	11
Prostate Cancer Survivorship Today: Support that Spans the Journey	11
How to Compose Platform Trials	11
Reply to Nikolaos Grivas, Sanchia Goonewardene, Wouter Everaerts, Nikolaos Kalampokis’s Letter to the Editor re: Andrea Mari, Riccardo Tellini, Francesco Porpiglia, et al. Perioperative and Mid-term O	11
Re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. Eur Urol Focus. In press. https://doi.	11
Urologic Oncology Survivorship Guidelines: An Overview of the Evidence and the Current Implementation Gap	11
Reply to Mitchell G. Goldenberg and Giovanni E. Cacciamani’s Letter to the Editor re: Gopal Sharma, Milap Shah, Puneet Ahluwalia, et al. Development and Validation of a Nomogram Predicting Intraoperat	11
Value of Different Magnetic Resonance Imaging-based Measurements of Anatomical Structures on Preoperative Prostate Imaging in Predicting Urinary Continence After Radical Prostatectomy in Men with Pros	11
Evidence based Urology: The Gist Leading Us to the Evidence for Decisions	11
Neoadjuvant Leuprolide Therapy with Radical Prostatectomy: Long-term Effects on Health-related Quality of Life	11
Limitations of Prostate Biopsy in Detection of Cribriform and Intraductal Prostate Cancer	10
Stratification of Intermediate-risk Non–muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies	10
Expectations Facing Reality: Complication Management after Aquablation Treatment for Lower Urinary Tract Symptoms	10
Top 100 Urology Influencers on Twitter: Is Social Media Influence Associated with Academic Impact?	10
Cytoreductive Surgery in Patients with Urothelial Bladder Cancer	10
Re: Marie-Aimée Perrouine-Verbe, Marcus J. Drake, Laura Thomas. The Challenges of Real-life Bladder Diary Use and Interpretation. Eur Urol Focus 2022;8:11–7	10
The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer	10
Reply to Nikolaos Grivas and Henk G. van der Poel’s Letter to the Editor re: Rui Farinha, Giuseppe Rosiello, Artur De Oliveira Paludo, et al. Selective Suturing or Sutureless Technique in Robot-assist	10
A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance	10
Deep Learning–based Recurrence Prediction in Patients with Non–muscle-invasive Bladder Cancer	10
Re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.	10
A Patient-centred Approach to Fertility Management for Testicular Cancer Patients	10
Artificial INtelligence to Support Informed DEcision-making (INSIDE) for Improved Literature Analysis in Oncology	10
Interpreting and Appraising Noninferiority Trials: A Guide for Urologists and Clinicians	10
Which Biomarkers are Useful in the Management of Muscle-invasive Bladder Cancer in 2022?	10
Percutaneous Ablation Versus Surgical Resection for Local Recurrence Following Partial Nephrectomy for Renal Cell Cancer: A Propensity Score Analysis (REPART Study—UroCCR 71)	10
Diagnostic Tests for Female Bladder Outlet Obstruction: A Systematic Review from the European Association of Urology Non-neurogenic Female LUTS Guidelines Panel	10
Editorial Board	10
Association of Severe Microscopic Hematuria with Successful Conservative Treatment of Single Uncomplicated Ureteral Calculus: A Multicenter Cohort Study	10
Editorial Board	10
The Impact of Centralised Services on Metric Reflecting High-quality Performance: Outcomes from 1110 Consecutive Radical Cystectomies at a Single Centre	9
Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma	9
Emerging Role of Mobile Applications and Wearable Devices for Prehabilitation in Urologic Oncology	9
Re: Jordan M. Rich, Kennedy E. Okhawere, Charles Nguyen, et al. Transperitoneal Versus Retroperitoneal Single-port Robotic-assisted Partial Nephrectomy: An Analysis from the Single Port Advanced Resea	9
Qualitative Assessment of the Conservative Management of Nocturia with Standardised Written Materials for Lower Urinary Tract Symptoms in Men Treated in Primary Care	9
Reply to Francesco Montorsi, Eugenio Ventimiglia, and Andrea Salonia’s Letter to the Editor re: Panagiotis Kallidonis, Constantinos Adamou, Dimitrios Kotsiris, et al. Combination Therapy with Alpha-bl	9
Re: Britta Grüne, Fabian Siegel, Frank Waldbillig, et al. Long-term Reinterventions after Thulium Laser Enucleation of the Prostate: 12-Year Experience with more than 1000 Patients. Eur Urol Focus. In	9
Differences in Quality of Life between German and Dutch Patients with Prostate Cancer Treated with Robot-assisted Radical Prostatectomy: Implications for International Multicenter Randomized Controlle	9
Secondary Bladder Cancer After Prostate Cancer Treatment: An Age-matched Comparison Between Radiation and Surgery	9
Lifestyle Factors in Patients with Bladder Cancer: A Contemporary Picture of Tobacco Smoking, Electronic Cigarette Use, Body Mass Index, and Levels of Physical Activity	9
Predicting Complications After Robotic Partial Nephrectomy: Back to Simplicity	9
Recurrent Gleason Score 6 Prostate Cancer After Radiotherapy or Ablation: Should We Observe Them All? Results from a Large Multicenter Salvage Radical Prostatectomy Consortium	9
Re: Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis. Eur Urol Focu	9
Re: Luis Alberto Dorantes-Carrillo, Mario Basulto-Martínez, Rodrigo Suárez-Ibarrola, et al. Retrograde Intrarenal Surgery Versus Miniaturized Percutaneous Nephrolithotomy for Kidney Stones >1 cm: A	9
I Can’t Get No Satisfaction: Patient-reported Outcomes After Different Treatment Options for Lower Urinary Tract Symptoms	9
Prostatic Artery Embolization in Patients with Prostate Cancer: A Systematic Review	9
Prostate-specific Membrane Antigen Theranostics for Prostate Cancer Care: A Need to Prove Clinical Utility	9
Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study	9
Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting	9
Overactive Bladder as a Key Driver of Nocturia: The Argument Against	9
Genomic Sequencing Should Be Part of the Standard of Care for Most Urologic Cancers: For	9
Reply to Kun-Peng Li, Shun Wan, Chen-Yang Wang, and Li Yang’s Letter to the Editor re: Tatsushi Kawada, Ekaterina Laukhtina, Fahad Quhal, et al. Oncologic and Safety Outcomes for Endoscopic Surgery Ve	9
Systematic Review of Efficacy and Health Economic Implications of Real-world Treatment Sequencing in Prostate Cancer: Where Do the Newer Agents Enzalutamide and Abiraterone Fit in?	9
Outcomes of Robot-assisted Radical Prostatectomy with the Hugo RAS Surgical System: Initial Experience at a High-volume Robotic Center	9
Contents	9
Re: Steven MacLennan, Eilidh Duncan, Ted A. Skolarus, et al. Improving Guideline Adherence in Urology. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.10.007	9
Does Testicular Sperm Improve Intracytoplasmic Sperm Injection Outcomes for Nonazoospermic Infertile Men with Elevated Sperm DNA Fragmentation? A Systematic Review and Meta-analysis	9
Radiation Exposure During Prostatic Artery Embolisation: A Systematic Review and Calculation of Associated Risks	8
Risks of Dementia After Treatment with an Anticholinergic, Beta-3 Agonist, or Combination of Both for an Overactive Bladder: A Korean National Cohort Study	8
Erectile Dysfunction Is Associated with Left Ventricular Diastolic Dysfunction: A Systematic Review and Meta-analysis	8
Contents	8
Efficacy and Safety of Surgical Treatments for Neurogenic Stress Urinary Incontinence in Adults: A Systematic Review	8
Characterization of Changes in Penile Microbiome Following Pediatric Circumcision	8
Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non–muscle-invasive	8
The Growing Role for Semantic Segmentation in Urology	8
Feasibility of Next-generation Sequencing of Liquid Biopsy (Circulating Tumor DNA) Samples and Tumor Tissue from Patients with Metastatic Prostate Cancer in a Real-world Clinical Setting in Germany	8
What Is the Malignant Potential of Small (<2 cm), Nonpalpable Testicular Incidentalomas in Adults? A Systematic Review	8
Pharmacologic and Surgical Retreatment After Office-based Treatments for Benign Prostatic Hyperplasia: A Systematic Review	8
Prehabilitation: A multidimensional adjunct to comprehensive personalized oncologic care. But, can we make it pragmatic?	8
Transition to Value-based Healthcare: Development, Implementation, and Results of an Optimal Surgical Care Framework at a National Cancer Institute–designated Comprehensive Cancer Center	8